RelB NF-κB represses estrogen receptor α expression via induction of the zinc finger protein Blimp1

Molecular and Cellular Biology

Volumn 29, Issue 14, 2009, Pages 3832-3844

  Wang, Xiaobo ^a,c   Belguise, Karine ^a,d   O'Neill, Christine F ^a,e   Sánchez Morgan, Nuria ^a   Romagnoli, Mathilde ^a   Eddy, Sean F ^a,f   Mineva, Nora D ^a   Yu, Ziyang ^a   Min, Chengyin ^a   Trinkaus Randall, Vickery ^a   Chalbos, Dany ^b   Sonenshein, Gail E ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CENTRE VAL D AURELLE   (France)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d INSTITUT DE RECHERCHE EN CANCÉROLOGIE DE MONTPELLIER   (France)

^e Maine Medical Center Research Institute   (United States)

^f Genstruct Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE INDUCED MATURATION PROTEIN 1; BETA ACTIN; ESTROGEN RECEPTOR ALPHA; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LAMIN B; PLAKOGLOBIN; PROTEIN BCL 2; PROTEIN P50; PROTEIN P52; RAS PROTEIN; TRANSCRIPTION FACTOR RELB; UVOMORULIN; ZINC FINGER PROTEIN; PRDM1 PROTEIN, HUMAN; PRIMER DNA; RELB PROTEIN, HUMAN; REPRESSOR PROTEIN;

ARTICLE; B LYMPHOCYTE; BCL2 GENE; BREAST CANCER; BREAST TUMOR; CANCER CELL; CARCINOGENESIS; CELL MIGRATION; CONTROLLED STUDY; GENE EXPRESSION; GENE INDUCTION; GENE REPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MITOCHONDRION; ONCOGENE; PHENOTYPE; PRDM1 GENE; PRIORITY JOURNAL; PROTEIN INDUCTION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; SYNTHESIS; T LYMPHOCYTE; BIOSYNTHESIS; CELL MOTION; FEMALE; GENETICS; METABOLISM; NEOPLASM; NUCLEOTIDE SEQUENCE; PROTO ONCOGENE; TUMOR CELL LINE;

BASE SEQUENCE; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; DNA PRIMERS; ESTROGEN RECEPTOR ALPHA; FEMALE; GENE EXPRESSION; GENES, BCL-2; HUMANS; NEOPLASMS, HORMONE-DEPENDENT; PHENOTYPE; PROTO-ONCOGENE PROTEINS C-BCL-2; RAS PROTEINS; REPRESSOR PROTEINS; TRANSCRIPTION FACTOR RELB;

EID: 67650034863     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.00032-09     Document Type: Article

References (64)

1. Angelin-Duclos, C., K. Johnson, J. Liao, K. I. Lin, and K. Calame. 2002. An interfering form of Blimp-1 increases IgM secreting plasma cells and blocks maturation of peripheral B cells. Eur. J. Immunol. 32:3765-3775.
2. Bild, A. H., G. Yao, J. T. Chang, Q. Wang, A. Potti, D. Chasse, M. B. Joshi, D. Harpole, J. M. Lancaster, A. Berchuck, J. A. Olson, Jr., J. R. Marks, H. K. Dressman, M. West, and J. R. Nevins. 2006. Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Nature 439:353-357.
3. Blagosklonny, M. V., T. Schulte, P. Nguyen, J. Trepel, and L. M. Neckers. 1996. Taxol-induced apoptosis and phosphorylation of Bcl-2 protein involves c-Raf-1 and represents a novel c-Raf-1 signal transduction pathway. Cancer Res. 56:1851-1854.
4. Bonizzi, G., M. Bebien, D. C. Otero, K. E. Johnson-Vroom, Y. Cao, D. Vu, A. G. Jegga, B. J. Aronow, G. Ghosh, R. C. Rickert, and M. Karin. 2004. Activation of IKKα target genes depends on recognition of specific κB binding sites by RelB:p52 dimers. EMBO J. 23:4202-4210.
5. Cadwallader, K. A., H. Paterson, S. G. Macdonald, and J. F. Hancock. 1994. N-terminally myristoylated Ras proteins require palmitoylation or a polybasic domain for plasma membrane localization. Mol. Cell. Biol. 14:4722-4730.
6. Calame, K. L., K. I. Lin, and C. Tunyaplin. 2003. Regulatory mechanisms that determine the development and function of plasma cells. Annu. Rev. Immunol. 21:205-230.
7. Choi, J., K. Choi, E. N. Benveniste, S. B. Rho, Y. S. Hong, J. H. Lee, J. Kim, and K. Park. 2005. Bcl-2 promotes invasion and lung metastasis by inducing matrix metalloproteinase-2. Cancer Res. 65:5554-5560.
8. Choy, E., V. K. Chiu, J. Silletti, M. Feoktistov, T. Morimoto, D. Michaelson, I. E. Ivanov, and M. R. Philips. 1999. Endomembrane trafficking of ras: the CAAX motif targets proteins to the ER and Golgi. Cell 98:69-80.
9. Cogswell, P. C., D. C. Guttridge, W. K. Funkhouser, and A. S. Baldwin, Jr. 2000. Selective activation of NF-κB subunits in human breast cancer: potential roles for NF-κB2/p52 and for Bcl-3. Oncogene 19:1123-1131.
10. Davis, M. M. 2007. Blimp-1 over Budapest. Nat. Immunol. 8:445-447.
11. deConinck, E. C., L. A. McPherson, and R. J. Weigel. 1995. Transcriptional regulation of estrogen receptor in breast carcinomas. Mol. Cell. Biol. 15:2191-2196.
12. deGraffenried, L. A., S. G. Hilsenbeck, and S. A. Fuqua. 2002. Sp1 is essential for estrogen receptor alpha gene transcription. J. Steroid Biochem. Mol. Biol. 82:7-18.
13. deGraffenried, L. A., T. A. Hopp, A. J. Valente, R. A. Clark, and S. A. Fuqua. 2004. Regulation of the estrogen receptor alpha minimal promoter by Sp1, USF-1, and ERα. Breast Cancer Res. Treat. 85:111-120.
14. Demicco, E. G., K. T. Kavanagh, R. Romieu-Mourez, X. Wang, S. R. Shin, E. Landesman-Bollag, D. C. Seldin, and G. E. Sonenshein. 2005. RelB/p52 NF-κB complexes rescue an early delay in mammary gland development in transgenic mice with targeted super-repressor IκB-alpha expression and promote carcinogenesis of the mammary gland. Mol. Cell. Biol. 25:10136-10147.
15. Denis, G. V., Q. Yu, P. Ma, L. Deeds, D. V. Faller, and C. Y. Chen. 2003. Bcl-2, via its BH4 domain, blocks apoptotic signaling mediated by mitochondrial Ras. J. Biol. Chem. 278:5775-5785.
16. Fink, P. J. 2006. T cells join the Blimp-1 brigade. Nat. Immunol. 7:445-446.
17. Grilli, M., J. J. Chiu, and M. J. Lenardo. 1993. NF-κB and Rel: participants in a multiform transcriptional regulatory system. Int. Rev. Cytol. 143:1-62.
18. Guo, S., and G. E. Sonenshein. 2004. Forkhead box transcription factor FOXO3a regulates estrogen receptor alpha expression and is repressed by the Her-2/neu/phosphatidylinositol 3-kinase/Akt signaling pathway. Mol. Cell. Biol. 24:8681-8690.
19. Gyory, I., J. Wu, G. Fejer, E. Seto, and K. L. Wright. 2004. PRDI-BF1 recruits the histone H3 methyltransferase G9a in transcriptional silencing. Nat. Immunol. 5:299-308.
20. Jeay, S., S. Pianetti, H. M. Kagan, and G. E. Sonenshein. 2003. Lysyl oxidase inhibits ras-mediated transformation by preventing activation of NF-κB. Mol. Cell. Biol. 23:2251-2263.
21. Jiang, H. Y., C. Petrovas, and G. E. Sonenshein. 2002. RelB-p50 NF-κB complexes are selectively induced by cytomegalovirus immediate-early protein 1: differential regulation of Bcl-x(L) promoter activity by NF-κB family members. J. Virol. 76:5737-5747.
22. Johnson, K., M. Shapiro-Shelef, C. Tunyaplin, and K. Calame. 2005. Regulatory events in early and late B-cell differentiation. Mol. Immunol. 42:749-761.
23. Kalaitzidis, D., and T. D. Gilmore. 2005. Transcription factor cross-talk: the estrogen receptor and NF-κB. Trends Endocrinol. Metab. 16:46-52.
24. Keller, A. D., and T. Maniatis. 1991. Identification and characterization of a novel repressor of beta-interferon gene expression. Genes Dev. 5:868-879.
25. Lernbecher, T., U. Muller, and T. Wirth. 1993. Distinct NF-κB/Rel transcription factors are responsible for tissue-specific and inducible gene activation. Nature 365:767-770.
26. Lessard, L., L. R. Begin, M. E. Gleave, A. M. Mes-Masson, and F. Saad. 2005. Nuclear localization of nuclear factor-κB transcription factors in prostate cancer: an immunohistochemical study. Br. J. Cancer 93:1019-1023.
27. Marienfeld, R., M. J. May, I. Berberich, E. Serfling, S. Ghosh, and M. Neumann. 2003. RelB forms transcriptionally inactive complexes with RelA/p65. J. Biol. Chem. 278:19852-19860.
28. Martins, G. A., L. Cimmino, M. Shapiro-Shelef, M. Szabolcs, A. Herron, E. Magnusdottir, and K. Calame. 2006. Transcriptional repressor Blimp-1 regulates T-cell homeostasis and function. Nat. Immunol. 7:457-465.
29. Mineva, N. D., X. Wang, S. Yang, H. Ying, Z.-X. J. Xiao, M. F. Holick, and G. E. Sonenshein. Inhibition of RelB by 1,25-dihydroxyvitamin D3 promotes sensitivity of breast cancer cells to radiation. J. Cell Physiol., in press.
30. Nakshatri, H., P. Bhat-Nakshatri, D. A. Martin, R. J. Goulet, Jr., and G. W. Sledge, Jr. 1997. Constitutive activation of NF-κB during progression of breast cancer to hormone-independent growth. Mol. Cell. Biol. 17:3629-3639.
31. Navarro, P., A. M. Valverde, M. Benito, and M. Lorenzo. 1999. Activated Ha-ras induces apoptosis by association with phosphorylated Bcl-2 in a mitogen-activated protein kinase-independent manner. J. Biol. Chem. 274:18857-18863.
32. Oh, A. S., L. A. Lorant, J. N. Holloway, D. L. Miller, F. G. Kern, and D. El-Ashry. 2001. Hyperactivation of MAPK induces loss of ERα expression in breast cancer cells. Mol. Endocrinol. 15:1344-1359.
33. Ohinata, Y., B. Payer, D. O'Carroll, K. Ancelin, Y. Ono, M. Sano, S. C. Barton, T. Obukhanych, M. Nussenzweig, A. Tarakhovsky, M. Saitou, and M. A. Surani. 2005. Blimp1 is a critical determinant of the germ cell lineage in mice. Nature 436:207-213.
34. Ohkubo, Y., M. Arima, E. Arguni, S. Okada, K. Yamashita, S. Asari, S. Obata, A. Sakamoto, M. Hatano, J. O.-Wang, M. Ebara, H. Saisho, and T. Tokuhisa. 2005. A role for c-fos/activator protein 1 in B lymphocyte terminal differentiation. J. Immunol. 174:7703-7710.
35. Omidvar, N., S. Kogan, S. Beurlet, C. le Pogam, A. Janin, R. West, M. E. Noguera, M. Reboul, A. Soulie, C. Leboeuf, N. Setterblad, D. Felsher, E. Lagasse, A. Mohamedali, N. S. Thomas, P. Fenaux, M. Fontenay, M. Pla, G. J. Mufti, I. Weissman, C. Chomienne, and R. A. Padua. 2007. BCL-2 and mutant NRAS interact physically and functionally in a mouse model of progressive myelodysplasia. Cancer Res. 67:11657-11667.
36. Puto, L. A., and J. C. Reed. 2008. Daxx represses RelB target promoters via DNA methyltransferase recruitment and DNA hypermethylation. Genes Dev. 22:998-1010.
37. Rayet, B., and C. Gelinas. 1999. Aberrant rel/nfkb genes and activity in human cancer. Oncogene 18:6938-6947.
38. Rebollo, A., D. Perez-Sala, and A. C. Martinez. 1999. Bcl-2 differentially targets K-, N-, and H-Ras to mitochondria in IL-2 supplemented or deprived cells: implications in prevention of apoptosis. Oncogene 18:4930-4939.
39. Ren, B., K. J. Chee, T. H. Kim, and T. Maniatis. 1999. PRDI-BF1/Blimp-1 repression is mediated by corepressors of the Groucho family of proteins. Genes Dev. 13:125-137.
40. Romieu-Mourez, R., D. W. Kim, S. M. Shin, E. G. Demicco, E. Landesman-Bollag, D. C. Seldin, R. D. Cardiff, and G. E. Sonenshein. 2003. Mouse mammary tumor virus c-rel transgenic mice develop mammary tumors. Mol. Cell. Biol. 23:5738-5754.
41. Schjerven, H., T. N. Tran, P. Brandtzaeg, and F. E. Johansen. 2004. De novo synthesized RelB mediates TNF-induced up-regulation of the human polymeric Ig receptor. J. Immunol. 173:1849-1857.
42. Sentman, C. L., J. R. Shutter, D. Hockenbery, O. Kanagawa, and S. J. Korsmeyer. 1991. bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes. Cell 67:879-888.
43. Sharma, D., J. Blum, X. Yang, N. Beaulieu, A. R. Macleod, and N. E. Davidson. 2005. Release of methyl CpG binding proteins and histone deacetylase 1 from the estrogen receptor alpha (ER) promoter upon reactivation in ER-negative human breast cancer cells. Mol. Endocrinol. 19:1740-1751.
44. Siebenlist, U., G. Franzoso, and K. Brown. 1994. Structure, regulation and function of NF-κB. Annu. Rev. Cell Biol. 10:405-455.
45. Sovak, M. A., R. E. Bellas, D. W. Kim, G. J. Zanieski, A. E. Rogers, A. M. Traish, and G. E. Sonenshein. 1997. Aberrant nuclear factor-κB/Rel expression and the pathogenesis of breast cancer. J. Clin. Investig. 100:2952-2960.
46. Stoffel, A., M. Chaurushiya, B. Singh, and A. J. Levine. 2004. Activation of NF-κB and inhibition of p53-mediated apoptosis by API2/mucosa-associated lymphoid tissue 1 fusions promote oncogenesis. Proc. Natl. Acad. Sci. USA 101:9079-9084.
47. Suhasini, M., C. D. Reddy, E. P. Reddy, J. A. DiDonato, and R. B. Pilz. 1997. cAMP-induced NF-κB (p50/relB) binding to a c-myb intronic enhancer correlates with c-myb up-regulation and inhibition of erythroleukemia cell differentiation. Oncogene 15:1859-1870.
48. Tanimoto, K., H. Eguchi, T. Yoshida, K. Hajiro-Nakanishi, and S. Hayashi. 1999. Regulation of estrogen receptor alpha gene mediated by promoter B responsible for its enhanced expression in human breast cancer. Nucleic Acids Res. 27:903-909.
49. Tunyaplin, C., M. A. Shapiro, and K. L. Calame. 2000. Characterization of the B lymphocyte-induced maturation protein-1 (Blimp-1) gene, mRNA isoforms and basal promoter. Nucleic Acids Res. 28:4846-4855.
50. van de Vijver, M. J., Y. D. He, L. J. van't Veer, H. Dai, A. A. Hart, D. W. Voskuil, G. J. Schreiber, J. L. Peterse, C. Roberts, M. J. Marton, M. Parrish, D. Atsma, A. Witteveen, A. Glas, L. Delahaye, T. van der Velde, H. Bartelink, S. Rodenhuis, E. T. Rutgers, S. H. Friend, and R. Bernards. 2002. A gene expression signature as a predictor of survival in breast cancer. N. Engl. J. Med. 347:1999-2009.
51. Van den Eynden, G. G., I. Van der Auwera, S. Van Laere, C. G. Colpaert, P. van Dam, S. Merajver, C. G. Kleer, A. L. Harris, E. A. Van Marck, L. Y. Dirix, and P. B. Vermeulen. 2004. Validation of a tissue microarray to study differential protein expression in inflammatory and non-inflammatory breast cancer. Breast Cancer Res. Treat. 85:13-22.
52. Van Laere, S. J., I. Van der Auwera, G. G. Van den Eynden, H. J. Elst, J. Weyler, A. L. Harris, P. van Dam, E. A. Van Marck, P. B. Vermeulen, and L. Y. Dirix. 2006. Nuclear factor-κB signature of inflammatory breast cancer by cDNA microarray validated by quantitative real-time reverse transcription-PCR, immunohistochemistry, and nuclear factor-κB DNA-binding. Clin. Cancer Res. 12:3249-3256.
53. Vilimas, T., J. Mascarenhas, T. Palomero, M. Mandal, S. Buonamici, F. Meng, B. Thompson, C. Spaulding, S. Macaroun, M. L. Alegre, B. L. Kee, A. Ferrando, L. Miele, and I. Aifantis. 2007. Targeting the NF-κB signaling pathway in Notch1-induced T-cell leukemia. Nat. Med. 13:70-77.
54. Vincent, S. D., N. R. Dunn, R. Sciammas, M. Shapiro-Shalef, M. M. Davis, K. Calame, E. K. Bikoff, and E. J. Robertson. 2005. The zinc finger transcriptional repressor Blimp1/Prdm1 is dispensable for early axis formation but is required for specification of primordial germ cells in the mouse. Development 132:1315-1325.
55. Wang, H. G., U. R. Rapp, and J. C. Reed. 1996. Bcl-2 targets the protein kinase Raf-1 to mitochondria. Cell 87:629-638.
56. Wang, X., K. Belguise, N. Kersual, K. H. Kirsch, N. D. Mineva, F. Galtier, D. Chalbos, and G. E. Sonenshein. 2007. Oestrogen signalling inhibits invasive phenotype by repressing RelB and its target BCL2. Nat. Cell Biol. 9:470-478.
57. Wang, X., and G. E. Sonenshein. 2005. Induction of the RelB NF-κB subunit by the cytomegalovirus IE1 protein is mediated via Jun kinase and c-Jun/Fra-2 AP-1 complexes. J. Virol. 79:95-105.
58. Weih, F., D. Carrasco, S. K. Durham, D. S. Barton, C. A. Rizzo, R. P. Ryseck, S. A. Lira, and R. Bravo. 1995. Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-κB/Rel family. Cell 80:331-340.
59. Xia, Y., S. Chen, Y. Wang, N. Mackman, G. Ku, D. Lo, and L. Feng. 1999. RelB modulation of IκBalpha stability as a mechanism of transcription suppression of interleukin-1α (IL-1α), IL-1β, and tumor necrosis factor alpha in fibroblasts. Mol. Cell. Biol. 19:7688-7696.
60. 3 in prostate cancer cells. Mol. Cancer Ther. 6:2048-2056.
61. Yan, J., J. Jiang, C. A. Lim, Q. Wu, H. H. Ng, and K. C. Chin. 2007. BLIMP1 regulates cell growth through repression of p53 transcription. Proc. Natl. Acad. Sci. USA 104:1841-1846.
62. Yan, L., S. J. Nass, D. Smith, W. G. Nelson, J. G. Herman, and N. E. Davidson. 2003. Specific inhibition of DNMT1 by antisense oligonucleotides induces re-expression of estrogen receptor-alpha (ER) in ER-negative human breast cancer cell lines. Cancer Biol. Ther. 2:552-556.
63. Yu, J., C. Angelin-Duclos, J. Greenwood, J. Liao, and K. Calame. 2000. Transcriptional repression by blimp-1 (PRDI-BF1) involves recruitment of histone deacetylase. Mol. Cell. Biol. 20:2592-2603.
64. Zhu, W., A. Cowie, G. W. Wasfy, L. Z. Penn, B. Leber, and D. W. Andrews. 1996. Bcl-2 mutants with restricted subcellular location reveal spatially distinct pathways for apoptosis in different cell types. EMBO J. 15:4130-4141.